Oliver Mikse

Principal Scientist Pharmacology at Rgenta Therapeutics

No bio yet

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Rgenta Therapeutics

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.


Industries

Employees

11-50

Links